Cargando…
Multidrug-resistant tuberculosis
BACKGROUND: With almost 9 million new cases each year, tuberculosis remains one of the most feared diseases on the planet. Led by the STOP-TB Partnership and WHO, recent efforts to combat the disease have made considerable progress in a number of countries. However, the emergence of mutated strains...
Autores principales: | Zager, Ellen M, McNerney, Ruth |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241599/ https://www.ncbi.nlm.nih.gov/pubmed/18221534 http://dx.doi.org/10.1186/1471-2334-8-10 |
Ejemplares similares
-
The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1)
por: Wegner, Marthe-Susanna, et al.
Publicado: (2018) -
Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy
por: McLaren, Zoë M., et al.
Publicado: (2016) -
Diagnostics for Developing Countries
por: McNerney, Ruth
Publicado: (2015) -
Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis
por: Yzquierdo, Sergio Luis, et al.
Publicado: (2006) -
Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing
por: Dheda, Keertan, et al.
Publicado: (2019)